PREDICTION OF THE ANTIHYPERTENSIVE RESPONSE TO ENALAPRIL

被引:44
作者
MEREDITH, PA
DONNELLY, R
ELLIOTT, HL
HOWIE, CA
REID, JL
机构
[1] University of Glasgow, Department of Medicine and Therapeutics, Stobhill General Hospital, Glasgow
关键词
ENALAPRIL; PHARMACOKINETICS; CONCENTRATION EFFECT; HYPERTENSION; PREDICTION; SIMULATION;
D O I
10.1097/00004872-199012000-00003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This study investigates the potential utility of a drug concentration-effect modelling approach to predict the long-term response to antihypertensive treatment with enalapril. Concentration-effect relationships were characterized in 13 subjects following a single dose of enalapril (20 mg) and for each individual the derived parameters were used to predict the steady-state blood pressure profile. The predicted responses (before dosing and 4 h after dosing) were in close agreement with the responses observed after 6 weeks. In individual patients, the observed and predicted blood pressure profiles over a 12 h period were compared. In six of the 13 subjects, there were statistically significant (P < 0.05) prediction errors. However, in all but one of these patients the error was < 10%, and for the group as a whole the mean prediction error was small and not statistically significant (-0.6 +/- 2.1 mmHg). The kinetic-dynamic parameters derived from observations of the first dose were used to simulate steady-state responses to several alternative doses and dose frequencies. A regimen of 10 mg twice daily increased the ratio of blood pressure at trough-to-peak response to 75 +/- 5% compared to 33 +/- 16% when 20 mg was given once daily. In addition, a twice-daily regimen reduced the coefficient of variation of the hourly average blood pressure. Thus, concentration-effect parameters derived from the first dose response to enalapril have potential not only for predicting long-term antihypertensive response, but also for optimizing dosage regimens for individual patients.
引用
收藏
页码:1085 / 1090
页数:6
相关论文
共 20 条
[1]   THE PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIPS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, CILAZAPRIL, IN ESSENTIAL-HYPERTENSION [J].
AJAYI, AA ;
ELLIOTT, HL ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :167-175
[2]   INDIVIDUAL-RESPONSES TO CONVERTING ENZYME-INHIBITORS AND CALCIUM-ANTAGONISTS [J].
BIDIVILLE, J ;
NUSSBERGER, J ;
WAEBER, G ;
PORCHET, M ;
WAEBER, B ;
BRUNNER, HR .
HYPERTENSION, 1988, 11 (02) :166-173
[3]  
Brunner H R, 1983, J Hypertens Suppl, V1, P103
[4]   LISINOPRIL - DOSE-PEAK EFFECT RELATIONSHIP IN ESSENTIAL-HYPERTENSION [J].
CIRILLO, VJ ;
GOMEZ, HJ ;
SALONEN, J ;
SALONEN, R ;
RISSANEN, V ;
BOLOGNESE, JA ;
NYBERG, R ;
KRISTIANSON, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) :533-538
[5]   HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE [J].
CRAMER, JA ;
MATTSON, RH ;
PREVEY, ML ;
SCHEYER, RD ;
OUELLETTE, VL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22) :3273-3277
[6]   AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF ENALAPRIL [J].
DAVIES, RO ;
GOMEZ, HJ ;
IRVIN, JD ;
WALKER, JF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 :S215-S229
[7]   NIFEDIPINE - INDIVIDUAL-RESPONSES AND CONCENTRATION-EFFECT RELATIONSHIPS [J].
DONNELLY, R ;
ELLIOTT, HL ;
MEREDITH, PA ;
KELMAN, AW ;
REID, JL .
HYPERTENSION, 1988, 12 (04) :443-449
[8]   KINETIC-DYNAMIC RELATIONS AND INDIVIDUAL-RESPONSES TO ENALAPRIL [J].
DONNELLY, R ;
MEREDITH, PA ;
ELLIOTT, HL ;
REID, JL .
HYPERTENSION, 1990, 15 (03) :301-309
[9]   PREDICTABILITY OF ANTIHYPERTENSIVE RESPONSIVENESS AND ALPHA-ADRENOCEPTOR ANTAGONISM DURING PRAZOSIN TREATMENT [J].
ELLIOTT, HL ;
DONNELLY, R ;
MEREDITH, PA ;
REID, JL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (05) :576-583
[10]  
Gomez H J, 1983, J Hypertens Suppl, V1, P65